CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report) saw a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 12,700 shares, an increase of 12,600.0% from the November 30th total of 100 shares. Based on an average daily trading volume, of 90,800 shares, the days-to-cover ratio is presently 0.1 days.
CSPC Pharmaceutical Group Price Performance
CSPC Pharmaceutical Group stock opened at C$2.40 on Friday. The company’s 50 day simple moving average is C$2.66 and its 200-day simple moving average is C$2.83. CSPC Pharmaceutical Group has a 1 year low of C$2.25 and a 1 year high of C$3.82.
CSPC Pharmaceutical Group Increases Dividend
The company also recently declared a dividend, which was paid on Thursday, December 5th. Stockholders of record on Friday, November 1st were given a dividend of $0.0575 per share. This is a positive change from CSPC Pharmaceutical Group’s previous dividend of $0.06. The ex-dividend date of this dividend was Friday, November 1st.
About CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, North America, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments.
See Also
- Five stocks we like better than CSPC Pharmaceutical Group
- Investing in the High PE Growth Stocks
- S&P 500 ETFs: Expense Ratios That Can Boost Your Long-Term Gains
- 3 Best Fintech Stocks for a Portfolio Boost
- How AI Implementation Could Help MongoDB Roar Back in 2025
- Trading Halts Explained
- Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon?
Receive News & Ratings for CSPC Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.